openPR Logo
Press release

The Global Immunoassay Instruments Market Was Valued At US$ 16,970 Mn In 2016 And Expected To Grow To US$ 24,200 Mn By 2021

03-15-2017 12:59 PM CET | Health & Medicine

Press release from: SA-BRC

The Global Immunoassay Instruments Market Was Valued At US$

Immunoassay instruments are used for measurement of molecules and pathogens, and are adopted significantly in disease diagnostics. The immunoassays instruments are majorly used in areas of pharmaceutical analysis, diagnosis of diseases, therapeutic drug monitoring, clinical pharmacokinetic among other research avenues. This report by SA-BRC focuses on the global immunoassay instruments market used for diagnostics and research across several major medical specialties. The report presents a lateral perspective on the global market through nine chapters covering immunoassay techniques by product type, end-users, applications and geography. The analysis covers various market drivers that are pushing growth of the market such as the rising demand of field deployable instruments, technological advancements, rising incidence of chronic diseases such as cancer, diabetes and hypertension among others and also provides notable factors hindering the growth. The global immunoassay instruments market was valued at US$ 16,970 million in 2016 and expected to grow to US$ 24,200 million by 2021 at a CAGR of 6.0% from 2017 to 2021.

Key players such as Hoffman La-Roche, Siemens Healthineers, Abbott Laboratories, Danaher Corporation, BioMerieux SA, DiaSorin, Becton Dickinson & Company and Ortho-Clinical Diagnostics, Inc. Abbott Laboratories continued to lead in the global immunoassay instruments market in 2016. Launch of new and innovative products and expanding geographic presence are some of the key growth strategies adopted by the company to retain their market presence.

The report covers following major segments and sub-segments:
The report segments the global immunoassay instruments market as follows:

Market by Products
Chemiluminescence Analyzers
Enzyme-Linked Immunosorbent Assay Analyzers (ELISA)
Immunofluorescence Assay Analyzers
Radioimmunoassay Analyzers
Multiplexed Assay Systems

Request Free Report Sample@ http://www.sa-brc.com/Global-Immunoassay-Instruments-Market-Assessment--Forecast-2017-2021/sample34

Market by Applications
Oncology
Cardiology
Endocrinology
Infectious Diseases
Autoimmune Diseases
Hematology
Others

Market by End-Users
Hospitals
Laboratories
Academic Institutions
Pharmaceutical Industry
Others

Market by Geography
North America
Europe
Asia Pacific
Latin America
Middle-East
Africa

For each of these segments and sub-segments, market estimates have been provided from 2015 to 2021 (historic data for 2015 and 2016, and forecast from 2017 to 2021)

The immunoassay instruments market report emphasizes on various products, applications and end-users:
The report segments the immunoassay instruments market in 3 broad perspectives, namely; product type, applications by medical specialty and end-users. Each segment provides qualitative and quantitative details on merits and demerits, growth drivers, and market trends.

More Report Description@ http://www.sa-brc.com/report/Global-Immunoassay-Instruments-Market-Assessment--Forecast-2017-2021/34

Extensive geographical analysis on the immunoassay instruments market:
The global immunoassay instruments market is segmented into six major geographies, namely North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Market for each of these regions is analyzed by immunoassay product types.

The report also explains other factors impacting the immunoassay instruments market:
Various factors driving and impeding the growth of the immunoassay instruments market are explained in the report. It also includes mentions of new regulatory policies, recent developments in the market and upcoming technologies expected to launch in the near future.

About Us
Spearhead Acuity Business Research & Consulting Private Limited (SA-BRC) is a premium Life Science business intelligence and data analytics firm. SA-BRC team offers a wide range of business intelligence services to multiple stakeholders such as Medical Device Manufacturers, Service Providers (Hospitals, Payers, etc.), Suppliers, Group Purchase Organizations, Distributors and all other individuals in the entire value chain of healthcare industry. Our research and consulting capabilities extend across several sub-domains within the sphere of Life Sciences such as Biotechnology, Healthcare IT, Medical Devices, Veterinary Sciences, Wellness Products and Pharmaceuticals.

Contact Us
John Whitmore
10685-B Hazelhurst Drive,
Suite 17411
Houston, Texas 77043,
United States
Phone: +1(832)-426-3701
Email: sales@sa-brc.com
Website: www.sa-brc.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Global Immunoassay Instruments Market Was Valued At US$ 16,970 Mn In 2016 And Expected To Grow To US$ 24,200 Mn By 2021 here

News-ID: 469310 • Views:

More Releases from SA-BRC

Biochip Market Analysis by Application and Trend 2017-2021
Biochip Market Analysis by Application and Trend 2017-2021
Biochips allow simultaneous testing of higher number of analytes to achieve high throughput and low cost per test. Nanotechnology has helped in miniaturization of devices to achieve higher performance standards. Microarrays are most important part of biochips which send signals to the biochip to deliver end results. Microfluidic biochips have become modern alternative to routine laboratories. Microfluidic technology which enables controlling flow of liquids in micro and pico quantities has
Acute Myeloid Leukemia Therapeutics Market Share, Analysis and Segments 2017-2021
Acute Myeloid Leukemia Therapeutics Market Share, Analysis and Segments 2017-202 …
Acute myeloid leukemia is a cancer of blood cells and involves proliferation of abnormal blood cell types and subsequent replacement of bone marrow with cancerous cells. Major leukemia types include myeloblastic, promyeloctic, myelomonocytic, monocytic, erythroleukemia, megakaryocytic. Treatment of leukemia mainly depends on the type of leukemia and stage. Acute myeloid leukemia therapeutics market is rich with branded as well as generic drugs classified under various classes including antineoplastic agents, corticosteroids, tyrosine
Companion Diagnostics Market Share, Trends Analysis: 2017-2021
Companion Diagnostics Market Share, Trends Analysis: 2017-2021
Companion diagnostics has revolutionized cancer therapeutics and enabled physicians to select specific treatment pattern from of myriad of drugs for cancer treatment. This has improved treatment outcome manyfold and has now become and indispensable part of personalized medicine. The companion diagnostics market received great attention post success of Herceptin (trastuzumab) and Gleevec (imatinib). Rapid adoption of companion diagnostics and supportive regulatory agencies have encouraged researchers to seek molecules that target
North America and Europe Bionic Eye Market Segment Analysis And Forecast: 2017-2021
North America and Europe Bionic Eye Market Segment Analysis And Forecast: 2017-2 …
Sudden surge in bionic eye market was experienced recently after the National Health Service (NHS) announced the sponsorship to implant bionic eyes in ten patients. The bionic eye can help regain vision in individuals with visual impairment. Although currently two bionic eye systems has received regulatory approvals, other companies in the bionic eye market are also trying to develop new technology that can help in regaining visual sense in patients. The

All 5 Releases


More Releases for Immunoassay

Insights On Immunoassay Market Outlook - Ken Research
An immunoassay is a biochemical analysis that measures the existence or concentration of a macromolecule or a small molecule in a solution through the use of an antibody or an antigen. Immunoassays in scientific research are typically used in the study of biological systems by tracing different proteins, hormones, and antibodies. In industry, they are used to identify contaminants in food and water, and to monitor specific molecules used during
Bahrain Immunoassay Analyzer Market
Transparent healthcare framework & strict procurement system enables the authorities in gaining the trust of the end-users leading to the growth of the medical devices industry in Bahrain: Ken Research Heavy Government involvement in the industry: Bahrain has been maintaining a basic framework for a transparent, rules-based government procurement system. Bahrain hospitals and clinics, as well as developing specialist treatments, are continuously growing. This has improved the installation of BGA, POC
Bahrain Immunoassay Analyzer Market: Ken Research
The report titled "Bahrain Blood Gas and POC Immunoassay AnalyzerMarket Outlook to 2026-Multiple programs to modernize the Bahraini healthcare sector in future including Health Insurance, Health centers and Primary Care Autonomy" provides a comprehensive analysis of the Diagnostic Equipments used in Hospitals and Independent Labs. Report also covers overview and genesis of the industry, product wise market size in terms of installed base; market segmentation by type of device, type
Immunoassay Market Competitive Dynamics 2027
According to the new research report published by The Insight Partners, titled "Immunoassay Market- Global Analysis and Forecast to 2027". The global immunoassay market is US$ 21,800.0 Mn in 2018 and is predicted to grow at a CAGR of 6.5% during the forecast period 2019 - 2027, to reach US$ 37,987.8 Mn by 2027. Immunoassay Market Report presents a competitive scenario of key Immunoassay Industry players with their market share, sales, revenue
Immunoassay Market: Opportunities and Challenges
The Immunoassay Market is expected to reach 27.15 billion by 2023 from USD 20.19 billion in 2018, at a CAGR of 6.1% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=436 Will the development of condition-specific biomarkers and tests create opportunities for growth for players in the immunoassay market? Biomarkers have gained significant clinical value and interest in the medical industry, as they are very useful in the screening, diagnosis, and treatment of diseases.
Immunoassay Growth Insights 2019 by Major Key Drivers like biotechnology and pha …
Immunoassay Market Highlights Immunoassay is widely used in significant areas of pharmaceutical analysis which include diagnosis of diseases and in therapeutic drug monitoring. A number of factors such as the increasing prevalence of chronic conditions, growth in the biotechnology and pharmaceutical sector, increasing adoption of rental immunoassay analyzers, rising use of immunoassay in oncology, growing awareness about immunoassay, healthcare insurance coverage for various infectious diseases, unmet medical needs, improving regulatory framework, and